Artificial intelligence applied to formulation design, process optimization, and quality assessment of three-dimensional-printed dosage forms and drug-delivery systems: a scoping review
Artificial intelligence applied to formulation design, process optimization, and quality assessment of three-dimensional-printed dosage forms and drug-delivery systems: a scoping review. // Intelligent Pharmacy. – URL: https://www.sciencedirect.com/science/article/pii/S2949866X26000791?dgcid=rss_sd_all
Artificial intelligence applied to formulation design, process optimization, and quality assessment of three-dimensional-printed dosage forms and drug-delivery systems: a scoping review. Intelligent Pharmacy. https://www.sciencedirect.com/science/article/pii/S2949866X26000791?dgcid=rss_sd_all
“Artificial intelligence applied to formulation design, process optimization, and quality assessment of three-dimensional-printed dosage forms and drug-delivery systems: a scoping review.” Intelligent Pharmacy.
@article{article30356,
title = {Artificial intelligence applied to formulation design, process optimization, and quality assessment of three-dimensional-printed dosage forms and drug-delivery systems: a scoping review},
journal = {Intelligent Pharmacy},
url = {https://www.sciencedirect.com/science/article/pii/S2949866X26000791?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...